课题基金 / 基金详情

PATHOGENESIS OF ALZHEIMERS DISEASE

PATHOGENESIS OF ALZHEIMERS DISEASE
阿尔茨海默病的发病机制
批准号:
2445863
负责人:
IAN S TROWBRIDGE
金额:
$25.88万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-01 至 2000-06-30

项目摘要

项目成果

IAN S TROWBRIDGE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long term goal of the proposed research is to understand the role of th B- amyloid precursor protein (APP) trafficking in the pathogenesis of Alzheime s disease. Recent studies have established that APP is an itinerant membrane protein which displays multiple cytoplasmic sorting signals. The cytoplasm tail of APP contains a sequence GYENPTY related to the 6-residue LDLR internalization signal FDNPVY as well as the segment YTSI which conforms th 4- residue tyrosine-based internalization consensus sequence. These signals a recognized by molecular sorting machinery located at different sites within he cell and determine the intracellular trafficking pathways along which APP i routed. Although there is evidence that AB can be generated from APP expre ed on the cell surface and that internalization is required, it is unclear whe er this is the exclusive or even the major trafficking pathway leading to the production of AB. The primary objectives of the present application are to determine how trafficking of APP influences AB production and whether APP trafficking is regulated by other gene products implicated in the pathogene s of AD. To accomplish these goals, the PI will take advantage of emerging conceptual and methodological advances in the field of membrane protein sor ng and apply them to APP trafficking. The major experimental approach will be o exploit transferrin receptor (TR) chimers including APP-TR chimera that all quantitative biochemical and morphological studies of membrane proteins to performed. The use of the TR chimeras allows unique properties of this rec tor- ligand system to be used to define membrane protein trafficking under a var ty of experimental conditions. The methods developed to modify protein traffi ing through the study of TR chimeras will be used to determine how altered APP trafficking affects AB production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTITUMOR THERAPY WIH ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODIES
  • 批准号:
    6102191
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1997
  • 负责人:
    IAN S TROWBRIDGE
  • 依托单位:
MEMBRANE PROTEIN SORTING IN POLARIZED CELLS
MEMBRANE PROTEIN SORTING IN POLARIZED CELLS
MEMBRANE PROTEIN SORTING IN POLARIZED CELLS
海外基金